Feb 10 (Reuters) - Infant Bacterial Therapeutics AB
 IBTb.ST :
    * SAID ON TUESDAY THAT JAPAN PATENT OFFICE HAS ISSUED A
DECISION
TO GRANT A PATENT 
    * PATENT FURTHER INCREASES THE EXISTING PROTECTION OF DRUG
CANDIDATE IBP-9414 FOR WHICH BOTH ORPHAN DRUG EXCLUSIVITY AND
BIOLOGICAL DATA PROTECTION HAVE BEEN GRANTED IN THE USA AND EU
    * JAPANESE PATENT EXPIRES IN 2036

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE9KmJll
    
 Further company coverage:  IBTb.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))